The only self-contained guide for practicing oncologists who treat patients with rare or infrequently encountered malignancies, this up-to-date resource offers a balanced, authoritative approach to the management of uncommon cancers. Now in its fourth edition, the book is thoroughly revised, including new material as well as new focus on evidence-based research and clinical practice throughout. Clinicians will find guidelines for addressing management issues, gain insight into real-world clinical decision-making, and save umpteen hours of research through the use of this widely acclaimed, comprehensive guide.

� propos de l?auteur

Derek Raghavan, MD, PhD, is President of the Levine Cancer Institute of the Carolinas Healthcare System in Charlotte, North Carolina. Widely published in journals and books, Dr. Raghavan has been the editor-in-chief of Textbook of Uncommon Cancer since its second edition. Charles D. Blanke, MD, is Chief of the Division of Oncology at the British Columbia Cancer Agency and Professor of Medicine at the University of British Columbia in Vancouver, Canada. David Johnson, MD, was the longtime Director of the Division of Hematology and Oncology at Vanderbilt University in Nashville, Tennessee, and was recently appointed as Chairman of Medicine and holds the Donald W. Seldin Distinguished Chair in Internal Medicine at the University of Texas Southwestern in Dallas, Texas. Paul L. Moots, M.D., Associate Professor of Neurology at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. Gregory H. Reaman, M.D., is Chair of the Children's Oncology Group at the Children s National Medical Center in Washington, DC. Peter G. Rose, MD, is Section Head and Fellowship Director of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the Cleveland Clinic. Mikkael A. Sekeres, MD, is Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute.

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.